Cargando…
New cyclopentaquinoline hybrids with multifunctional capacities for the treatment of Alzheimer’s disease
Alzheimer’s disease (AD) is the most common progressive form of brain neurodegeneration and the most prevailing cause of dementia. Unfortunately, the aetiology of AD is not completely studied but different factors are associated with the development of AD such as among others low level of acetylchol...
Autores principales: | Czarnecka, Kamila, Girek, Małgorzata, Maciejewska, Karolina, Skibiński, Robert, Jończyk, Jakub, Bajda, Marek, Kabziński, Jacek, Sołowiej, Przemysław, Majsterek, Ireneusz, Szymański, Paweł |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6080388/ https://www.ncbi.nlm.nih.gov/pubmed/29210299 http://dx.doi.org/10.1080/14756366.2017.1406485 |
Ejemplares similares
-
Discovery of New Cyclopentaquinoline Analogues as Multifunctional Agents for the Treatment of Alzheimer’s Disease
por: Czarnecka, Kamila, et al.
Publicado: (2019) -
New cyclopentaquinoline and 3,5-dichlorobenzoic acid hybrids with neuroprotection against oxidative stress for the treatment of Alzheimer’s disease
por: Czarnecka, Kamila, et al.
Publicado: (2023) -
New Tetrahydroacridine Hybrids with Dichlorobenzoic Acid Moiety Demonstrating Multifunctional Potential for the Treatment of Alzheimer’s Disease
por: Czarnecka, Kamila, et al.
Publicado: (2020) -
Novel Cyclopentaquinoline and Acridine Analogs as Multifunctional, Potent Drug Candidates in Alzheimer’s Disease
por: Maciejewska, Karolina, et al.
Publicado: (2022) -
Correction to: New cyclopentaquinoline hybrids with multifunctional capacities for the treatment of Alzheimer’s disease
Publicado: (2018)